Astrana Health, Inc. (ASTH)
USD 35.04
(-1.35%)
USD 35.04
(-1.35%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 321.01 Million USD | 39.96% |
| 2022 | 229.36 Million USD | 14.12% |
| 2021 | 200.98 Million USD | -22.86% |
| 2020 | 260.55 Million USD | 1.56% |
| 2019 | 256.55 Million USD | 1778.23% |
| 2018 | 13.65 Million USD | 118.44% |
| 2017 | 6.25 Million USD | 0.0% |
| 2015 | 188.76 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 433.57 Million USD | 35.06% |
| 2024 Q2 | 475.45 Million USD | 9.66% |
| 2023 FY | 321.01 Million USD | 39.96% |
| 2023 Q3 | 235.58 Million USD | 2.29% |
| 2023 Q4 | 321.01 Million USD | 36.26% |
| 2023 Q2 | 230.31 Million USD | 0.72% |
| 2023 Q1 | 228.67 Million USD | -0.3% |
| 2022 Q2 | 223.21 Million USD | 10.77% |
| 2022 FY | 229.36 Million USD | 14.12% |
| 2022 Q4 | 229.36 Million USD | 2.81% |
| 2022 Q3 | 223.1 Million USD | -0.05% |
| 2022 Q1 | 201.5 Million USD | 0.26% |
| 2021 Q2 | 200.61 Million USD | 0.0% |
| 2021 FY | 200.98 Million USD | -22.86% |
| 2021 Q3 | 199.86 Million USD | -0.37% |
| 2021 Q4 | 200.98 Million USD | 0.56% |
| 2020 FY | 260.55 Million USD | 1.56% |
| 2019 FY | 256.55 Million USD | 1778.23% |
| 2018 FY | 13.65 Million USD | 118.44% |
| 2017 FY | 6.25 Million USD | 0.0% |
| 2015 FY | 188.76 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 78.751% |
| Addus HomeCare Corporation | 175.18 Million USD | -83.246% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -222.083% |
| Amedisys, Inc. | 487.21 Million USD | 34.112% |
| American Oncology Network, Inc. | 128.32 Million USD | -150.157% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 78.588% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | -179.456% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -2846.156% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -5994.817% |
| COMPASS Pathways plc | 33.04 Million USD | -871.298% |
| DocGo Inc. | 46.49 Million USD | -590.395% |
| The Ensign Group, Inc. | 1.87 Billion USD | 82.845% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -635.68% |
| InnovAge Holding Corp. | 113.03 Million USD | -183.995% |
| Assure Holdings Corp. | 14.8 Million USD | -2068.281% |
| The Joint Corp. | 16.73 Million USD | -1818.239% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 37.184% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -48750.689% |
| ModivCare Inc. | 1.14 Billion USD | 71.843% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -96430.177% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -7078.873% |
| Option Care Health, Inc. | 1.16 Billion USD | 72.479% |
| P3 Health Partners Inc. | 124.64 Million USD | -157.551% |
| P3 Health Partners Inc. | 124.64 Million USD | -157.551% |
| The Pennant Group, Inc. | 329.63 Million USD | 2.614% |
| Surgery Partners, Inc. | 3.06 Billion USD | 89.515% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -129287.392% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | -167.925% |
| The Oncology Institute, Inc. | 119.81 Million USD | -167.925% |